混合成像:钙化评分与心肌灌注成像
综述讨论将冠状动脉钙化评分(CACS)与心肌灌注成像(MPI,包括PET和SPECT)整合的混合成像技术,可进行衰减校正并更精确追踪放射性示踪剂摄取。CACS加入MPI可提高检测阻塞性冠心病的诊断灵敏度,并能在MPI结果正常的患者中揭示沉默性冠状动脉粥样硬化。该策略有助于风险分层和指导他汀类等治疗决策,但仍需进一步研究以充分确立其临床获益。
要点
- 混合成像将CT与MPI整合,可在同一机架系统内完成衰减校正和冠状动脉钙化评分。
- CACS加入MPI可提高检测阻塞性冠心病的诊断灵敏度,并揭示MPI正常患者的沉默性粥样硬化。
- CACS有助于预测心脏事件并促进个体化风险管理,如启动他汀类和阿司匹林等干预。
核心结论
- 将CACS评估与MPI整合不仅有助于冠心病的早期检测和管理,还能优化治疗策略,通过更准确和个体化的方法改善患者护理。
- 作者指出需要进一步研究以充分确立CACS联合MPI在心血管风险评估临床评估中的获益。
研究设计与样本
- 本文为综述,讨论将冠状动脉钙化评分(CACS)纳入心肌灌注成像(MPI)方案如何提高检测阻塞性冠心病的诊断灵敏度。
- 综述引用多项研究说明CACS加入MPI可改善冠心病诊断结局,并讨论混合成像在指导治疗决策中不断演变的作用。
主要发现
- CACS加入MPI可提高检测阻塞性冠心病的诊断灵敏度,多项研究显示其改善了冠心病诊断结局。
- CACS可在MPI结果正常的患者中揭示沉默性冠状动脉粥样硬化,体现其增量诊断价值。
- CACS有助于识别动脉粥样硬化并预测潜在心脏事件,促进个体化风险管理和启动他汀类及阿司匹林等定制干预。
关键数值与推荐
- 混合成像常在同一机架系统内整合CT与MPI(PET或SPECT),可实现衰减校正(AC)、获取冠状动脉钙化评分(CACS)并更精确追踪放射性示踪剂摄取。
- CACS方法涉及评估冠状动脉中的钙化斑块。
临床怎么用
- CACS加入MPI方案可提高检测阻塞性冠心病的诊断灵敏度,并有助于更有效地对患者进行风险分层。
- CACS有助于识别动脉粥样硬化并预测潜在心脏事件,促进个体化风险管理及启动他汀类和阿司匹林等定制干预。
- 混合成像在指导治疗决策中作用不断演变,尤其涉及他汀类用于心血管预防。
局限性
- 作者指出需要进一步研究以充分确立CACS联合MPI在心血管风险评估临床评估中的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronary heart disease (CHD) remains the top cause of death due to cardiovascular conditions worldwide, with someone suffering a myocardial infarction every 40 seconds. This highlights the importance of non-invasive imaging technologies like myocardial perfusion imaging (MPI), which are crucial for detecting coronary artery disease (CAD) early, even before symptoms appear. However, the reliance solely on MPI has shifted due to its limitations in definitively ruling out atherosclerosis, leading to the adoption of hybrid imaging techniques. Hybrid imaging combines computed tomography (CT) with MPI techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT). This integration, often within a single gantry system, enhances the diagnostic accuracy by allowing for attenuation correction (AC), acquisition of the coronary artery calcium score (CACS), and more precise tracing of radiotracer uptake. The built-in CT in modern MPI systems assists in these functions, which is essential for better diagnosis and risk assessment in patients. The addition of CACS to MPI, a method involving the assessment of calcified plaque in coronary arteries, notably enhances diagnostic and prognostic capabilities. CACS helps in identifying atherosclerosis and predicting potential cardiac events, facilitating personalized risk management and the initiation of tailored interventions like statins and aspirin. Such comprehensive imaging strategies not only improve the accuracy of detecting CAD but also help in stratifying patient risk more effectively. In this paper, we discuss how the incorporation of CAC into MPI protocols enhances the diagnostic sensitivity for detecting obstructive CAD, as evidenced by several studies where the addition of CAC to MPI has led to improved outcomes in diagnosing CAD. Moreover, CAC has been shown to unmask silent coronary atherosclerosis in patients with normal MPI results, highlighting its incremental diagnostic value. We will discuss the evolving role of hybrid imaging in guiding therapeutic decisions, particularly the use of statins for cardiovascular prevention. The integration of CAC assessment with MPI not only aids in the early detection and management of CAD but also optimizes therapeutic strategies, enhancing patient care through a more accurate and personalized approach. Such advancements underscore the need for further research to fully establish the benefits of combining CAC with MPI in the clinical assessment of cardiovascular risk.
引用
- Nayfeh M, Sayed A, Alwan M, et al. Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging. Semin Nucl Med. 2024. PMID: 39034159. doi:10.1053/j.semnuclmed.2024.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。